4th Quarter - Report

AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY for AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY

Firm
Client
Income
—
Expenses
$250,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

11/13/2024: Coalition letter to Rep. McMorris Rodgers, Chair of House Energy & Commerce Committee, and Rep. Brett Guthrie, Chair of the Health Subcommittee of the Energy& Commerce Committee, on issues related to reform of the Medicare physician payment system. 11/13/2024: Coalition letter to Reps. Panetta, Bera, Ruiz, Schrier, Joyce, Bucshon, Miller-Meeks, and Murphy in support of the Medicare Patient Access and Practice Stabilization Act of 2024 (H.R. 10073); issues related to the Medicare physician fee schedule. 11/15/2024: Sign-on letter to House Speaker, House Minority Leader, Senate Majority Leader, and Senate Minority Leader in support of the Medicare Patient Access and Practice Stabilization Act of 2024 (H.R. 10073); issues related to the Medicare physician fee payment system. Issues related to hearing healthcare, in general. Issues pertaining to health information technology and electronic health records, in general. Issues pertaining to Graduate Medical Education, in general. Issues pertaining to healthcare liability reform, in general. Issues pertaining to prior authorization, the Improving Seniors Timely Access to Care Act (S. 4532 /H.R. 8702), and in general. Issues pertaining to Medicare physician reimbursement, related to the Strengthening Medicare for Patients and Providers Act (H.R. 2474) and the Preserving Seniors Access to Physicians Act of 2023 (H.R. 6683), and in general. Issues pertaining to Medicare allergy verification, the Penicillin Allergy Verification and Evaluation Act of 2024 (H.R. 9778), and in general.

LobbyistCovered position, as disclosed
HARRY DECABO —
MAURA FARRELL —

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 9778 (118th), H.R. 6683 (118th), S. 4532 (118th), H.R. 2474 (118th), H.R. 8702 (118th), H.R. 10073 (118th)

Medicare/Medicaid MMM

11/13/2024: Coalition letter to Rep. McMorris Rodgers, Chair of House Energy & Commerce Committee, and Rep. Brett Guthrie, Chair of the Health Subcommittee of the Energy& Commerce Committee, on issues related to reform of the Medicare physician payment system. 11/13/2024: Coalition letter to Reps. Panetta, Bera, Ruiz, Schrier, Joyce, Bucshon, Miller-Meeks, and Murphy in support of the Medicare Patient Access and Practice Stabilization Act of 2024 (H.R. 10073); issues related to the Medicare physician fee schedule. 11/15/2024: Sign-on letter to House Speaker, House Minority Leader, Senate Majority Leader, and Senate Minority Leader in support of the Medicare Patient Access and Practice Stabilization Act of 2024 (H.R. 10073); issues related to the Medicare physician fee payment system. Issues pertaining to Medicare allergy verification, the Penicillin Allergy Verification and Evaluation Act of 2024 (H.R. 9778), and in general. Issues related to hearing healthcare, in general. Issues pertaining to step therapy, in general. Issues pertaining to health information technology and electronic health records, in general. Issues pertaining to Graduate Medical Education, in general. Issues pertaining to healthcare liability reform, in general

LobbyistCovered position, as disclosed
HARRY DECABO —
MAURA FARRELL —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 10073 (118th), H.R. 9778 (118th)

Tobacco TOB

Issues pertaining to tobacco control, including the pending FDA rule on prohibiting menthol cigarettes, and in general.

LobbyistCovered position, as disclosed
HARRY DECABO —
MAURA FARRELL —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Budget/Appropriations BUD

11/13/2024: Coalition letter to Rep. McMorris Rodgers, Chair of House Energy & Commerce Committee, and Rep. Brett Guthrie, Chair of the Health Subcommittee of the Energy& Commerce Committee, on issues related to reform of the Medicare physician payment system. 11/13/2024: Coalition letter to Reps. Panetta, Bera, Ruiz, Schrier, Joyce, Bucshon, Miller-Meeks, and Murphy in support of the Medicare Patient Access and Practice Stabilization Act of 2024 (H.R. 10073); issues related to the Medicare physician fee schedule. 11/15/2024: Sign-on letter to House Speaker, House Minority Leader, Senate Majority Leader, and Senate Minority Leader in support of the Medicare Patient Access and Practice Stabilization Act of 2024 (H.R. 10073); issues related to the Medicare physician fee payment system. Issues pertaining to Medicare allergy verification, the Penicillin Allergy Verification and Evaluation Act of 2024 (H.R. 9778), and in general. Issues pertaining to the budget and appropriations, in general.

LobbyistCovered position, as disclosed
HARRY DECABO —
MAURA FARRELL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 9778 (118th), H.R. 10073 (118th)

Veterans VET

Issues pertaining to healthcare practice and the Federal Supremacy Clause at the Department of Veterans Affairs, in general.

LobbyistCovered position, as disclosed
HARRY DECABO —
MAURA FARRELL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.